Active — Not RecruitingNot Applicable

India HIV-CervCa Project

India180 participantsStarted 2021-02-09

Plain-language summary

The investigators propose to prospectively study the difference in treatment (CTRT) completion and toxicities between HIV positive and HIV negative women in India with locally advanced cervical cancer receiving CTRT.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with newly biopsy proven squamous carcinoma or adenocarcinoma of the uterine cervix, FIGO stage IB2-IIIB in whom curative CTRT is planned * Karnofsky performance status ≥ 70 * Patients with lower paraortic lymph nodes (below the level of L2 vertebra) * patients diagnosed with cervical cancer whom also HIV positive or HIV negative Exclusion Criteria: * patients with active tuberculosis

What they're measuring

Completion Rates of Cancer Treatment

Timeframe: 2 years

Impact of HIV Infection on acute toxicities

Timeframe: 2 years

Trial details

NCT IDNCT07167069

SponsorAbramson Cancer Center at Penn Medicine

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-05

View on ClinicalTrials.gov More HIV Positive trials